No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs544471054 |
chr7:6893443-6893444 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs556439755 |
chr7:6893444-6893445 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs142366790 |
chr7:6893504-6893505 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs574510526 |
chr7:6893513-6893514 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs12532586 |
chr7:6893531-6893532 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs12537882 |
chr7:6893547-6893548 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs62440019 |
chr7:6893583-6893584 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs545504864 |
chr7:6893589-6893590 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs563695062 |
chr7:6893599-6893600 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs565447149 |
chr7:6893600-6893601 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs550173610 |
chr7:6893610-6893611 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs373370794 |
chr7:6893634-6893635 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs12530763 |
chr7:6893663-6893664 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs186523382 |
chr7:6893671-6893672 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs12532605 |
chr7:6893693-6893694 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs566168876 |
chr7:6893700-6893701 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs373398812 |
chr7:6893707-6893708 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs570990838 |
chr7:6893708-6893709 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs190346053 |
chr7:6893727-6893728 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs57024993 |
chr7:6893728-6893729 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs570036096 |
chr7:6893735-6893736 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs116755401 |
chr7:6893747-6893748 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs537455849 |
chr7:6893825-6893826 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs556166295 |
chr7:6893841-6893842 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs574702735 |
chr7:6893872-6893873 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs541651395 |
chr7:6893882-6893883 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs553894103 |
chr7:6893908-6893909 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs571914885 |
chr7:6893911-6893912 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs545467032 |
chr7:6893920-6893921 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs538411220 |
chr7:6893925-6893926 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs575617428 |
chr7:6893956-6893957 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs113351223 |
chr7:6893968-6893969 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs556598718 |
chr7:6893971-6893972 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs34583677 |
chr7:6893980-6893981 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs377756950 |
chr7:6894005-6894006 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs12532674 |
chr7:6894015-6894016 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs562242105 |
chr7:6894139-6894140 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs61572847 |
chr7:6894155-6894156 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs529630647 |
chr7:6894179-6894180 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs60135611 |
chr7:6894182-6894183 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs559938663 |
chr7:6894216-6894217 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs61140967 |
chr7:6894222-6894223 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs62440020 |
chr7:6894346-6894347 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs570194867 |
chr7:6894361-6894362 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs537027534 |
chr7:6894415-6894416 |
Active TSS Bivalent/Poised TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs74910503 |
chr7:6894420-6894421 |
Active TSS Bivalent/Poised TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs76268920 |
chr7:6894446-6894447 |
Active TSS Bivalent/Poised TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs376026713 |
chr7:6894449-6894450 |
Active TSS Bivalent/Poised TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs75594764 |
chr7:6894467-6894468 |
Active TSS Bivalent/Poised TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs190975628 |
chr7:6894491-6894492 |
Active TSS Bivalent/Poised TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|